SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-19-000116
Filing Date
2019-01-03
Accepted
2019-01-03 07:31:30
Documents
3
Period of Report
2019-01-03
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K dmtp20190102_8k.htm 8-K 24274
2 EXHIBIT 99.1 ex_132340.htm EX-99.1 16077
3 diamedica8kimage01.jpg GRAPHIC 10139
  Complete submission text file 0001437749-19-000116.txt   55696
Mailing Address 2 CARLSON PARKWAY SUITE 260 MINNEAPOLIS MN 55447
Business Address 2 CARLSON PARKWAY SUITE 260 MINNEAPOLIS MN 55447 (763) 496-5454
DiaMedica Therapeutics Inc. (Filer) CIK: 0001401040 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36291 | Film No.: 19503632
SIC: 2834 Pharmaceutical Preparations